Amprius Technologies (NYSE:AMPX) Director Sells $2,986,045.44 in Stock

Amprius Technologies, Inc. (NYSE:AMPX) Director Steven Chu sold 166,632 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $17.92, for a total value of $2,986,045.44. Following the completion of the transaction, the director directly owned 127,339 shares in the company, valued at approximately $2,281,914.88. The trade was a 56.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Steven Chu also recently made the following trade(s):

• On Thursday, March 12th, Steven Chu sold 155,565 shares of Amprius Technologies stock. The shares were sold at an average price of $18.50, for a total value of $2,877,952.50.

Amprius Technologies Price Performance

Shares of Amprius Technologies stock opened at $17.93 on Friday. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -52.72 and a beta of 3.04. The stock has a 50-day simple moving average of $11.88 and a 200-day simple moving average of $11.10. Amprius Technologies, Inc. has a 52-week low of $1.80 and a 52-week high of $19.40.

Amprius Technologies (NYSE:AMPX) last released its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $25.23 million for the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities research analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Alberta Investment Management Corp acquired a new position in Amprius Technologies during the 4th quarter worth $1,001,000. Vident Advisory LLC bought a new stake in Amprius Technologies during the fourth quarter valued at about $107,000. Summit Securities Group LLC acquired a new stake in shares of Amprius Technologies in the fourth quarter valued at about $54,000. Numerai GP LLC grew its position in shares of Amprius Technologies by 29.1% in the fourth quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock valued at $759,000 after purchasing an additional 21,698 shares during the last quarter. Finally, Osterweis Capital Management Inc. increased its stake in shares of Amprius Technologies by 142.6% in the fourth quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock worth $3,589,000 after purchasing an additional 267,385 shares during the period. Institutional investors own 5.04% of the company’s stock.

Key Headlines Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

Analyst Ratings Changes

AMPX has been the subject of several analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Amprius Technologies in a research note on Tuesday, March 10th. Oppenheimer reissued an “outperform” rating and set a $17.00 target price on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. B. Riley Financial increased their price objective on Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a report on Monday, March 9th. Finally, Roth Mkm reissued a “buy” rating and issued a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a research note on Friday, March 6th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Amprius Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.